Ameriprise’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.2M | Sell |
267,328
-257,994
| -49% | -$1.34M | ﹤0.01% | 3211 |
|
|
2025
Q4 | $3.23M | Sell |
525,322
-17,750
| -3% | -$129K | ﹤0.01% | 2743 |
|
|
2025
Q3 | $3.93M | Buy |
543,072
+126,630
| +30% | +$752K | ﹤0.01% | 2605 |
|
|
2025
Q2 | $2.21M | Buy |
416,442
+217,796
| +110% | +$1.29M | ﹤0.01% | 2898 |
|
|
2025
Q1 | $1.76M | Sell |
198,646
-11,269
| -5% | -$135K | ﹤0.01% | 2959 |
|
|
2024
Q4 | $2.88M | Sell |
209,915
-21,904
| -9% | -$404K | ﹤0.01% | 2718 |
|
|
2024
Q3 | $6.35M | Sell |
231,819
-21,599
| -9% | -$585K | ﹤0.01% | 2206 |
|
|
2024
Q2 | $6.2M | Sell |
253,418
-9,539
| -4% | -$209K | ﹤0.01% | 2142 |
|
|
2024
Q1 | $5.61M | Sell |
262,957
-8,007
| -3% | -$172K | ﹤0.01% | 2282 |
|
|
2023
Q4 | $5.19M | Buy |
270,964
+863
| +0.3% | +$14.9K | ﹤0.01% | 2322 |
|
|
2023
Q3 | $4.33M | Sell |
270,101
-27,052
| -9% | -$515K | ﹤0.01% | 2392 |
|
|
2023
Q2 | $6.89M | Sell |
297,153
-13,740
| -4% | -$300K | ﹤0.01% | 2098 |
|
|
2023
Q1 | $7.22M | Sell |
310,893
-7,749
| -2% | -$157K | ﹤0.01% | 2036 |
|
|
2022
Q4 | $4.62M | Sell |
318,642
-161,485
| -34% | -$3.01M | ﹤0.01% | 2340 |
|
|
2022
Q3 | $9.16M | Sell |
480,127
-222,091
| -32% | -$5.1M | ﹤0.01% | 1758 |
|
|
2022
Q2 | $12.8M | Sell |
702,218
-18,208
| -3% | -$378K | ﹤0.01% | 1539 |
|
|
2022
Q1 | $18.2M | Buy |
720,426
+5,562
| +0.8% | +$142K | 0.01% | 1434 |
|
|
2021
Q4 | $19.7M | Buy |
714,864
+60,795
| +9% | +$1.76M | 0.01% | 1417 |
|
|
2021
Q3 | $21.1M | Buy |
654,069
+306,339
| +88% | +$10.2M | 0.01% | 1221 |
|
|
2021
Q2 | $10.6M | Buy |
347,730
+1,061
| +0.3% | +$30.7K | ﹤0.01% | 1889 |
|
|
2021
Q1 | $10.6M | Buy |
346,669
+18,699
| +6% | +$531K | ﹤0.01% | 1845 |
|
|
2020
Q4 | $6.49M | Sell |
327,970
-120,622
| -27% | -$1.95M | ﹤0.01% | 2088 |
|
|
2020
Q3 | $5.85M | Buy |
448,592
+78,527
| +21% | +$994K | ﹤0.01% | 1966 |
|
|
2020
Q2 | $4.2M | Sell |
370,065
-2,988
| -0.8% | -$42.4K | ﹤0.01% | 2186 |
|
|
2020
Q1 | $5.34M | Sell |
373,053
-100,475
| -21% | -$2.12M | ﹤0.01% | 1866 |
|
|
2019
Q4 | $12.9M | Buy |
473,528
+26,979
| +6% | +$742K | 0.01% | 1541 |
|
|
2019
Q3 | $12.8M | Buy |
446,549
+331
| +0.1% | +$9.64K | 0.01% | 1498 |
|
|
2019
Q2 | $12.4M | Sell |
446,218
-38,164
| -8% | -$1.08M | 0.01% | 1560 |
|
|
2019
Q1 | $16.1M | Sell |
484,382
-14,660
| -3% | -$446K | 0.01% | 1293 |
|
|
2018
Q4 | $14.5M | Sell |
499,042
-4,150
| -0.8% | -$149K | 0.01% | 1290 |
|
|
2018
Q3 | $23.1M | Buy |
503,192
+64,431
| +15% | +$2.86M | 0.01% | 1186 |
|
|
2018
Q2 | $16.4M | Buy |
438,761
+1,095
| +0.3% | +$37K | 0.01% | 1323 |
|
|
2018
Q1 | $12.9M | Buy |
437,666
+15,490
| +4% | +$524K | 0.01% | 1454 |
|
|
2017
Q4 | $14.5M | Buy |
422,176
+6,359
| +2% | +$215K | 0.01% | 1310 |
|
|
2017
Q3 | $15M | Sell |
415,817
-1,571
| -0.4% | -$44.8K | 0.01% | 1260 |
|
|
2017
Q2 | $10.8M | Buy |
417,388
+53,263
| +15% | +$1.13M | 0.01% | 1494 |
|
|
2017
Q1 | $6.99M | Buy |
+364,125
| New | +$6.45M | ﹤0.01% | 1779 |
|
|
2016
Q3 | – | Sell |
-51,592
| Closed | -$1.58M | – | 3816 |
|
|
2016
Q2 | $1.58M | Buy |
51,592
+43,663
| +551% | +$1.52M | ﹤0.01% | 2643 |
|
|
2016
Q1 | $297K | Sell |
7,929
-694
| -8% | -$26.1K | ﹤0.01% | 3372 |
|
|
2015
Q4 | $372K | Sell |
8,623
-62,372
| -88% | -$2.64M | ﹤0.01% | 3392 |
|
|
2015
Q3 | $2.66M | Sell |
70,995
-37,636
| -35% | -$1.34M | ﹤0.01% | 2456 |
|
|
2015
Q2 | $3.69M | Sell |
108,631
-37,432
| -26% | -$1.27M | ﹤0.01% | 2345 |
|
|
2015
Q1 | $5.17M | Sell |
146,063
-105,588
| -42% | -$3.78M | ﹤0.01% | 2094 |
|
|
2014
Q4 | $8.57M | Sell |
251,651
-51,696
| -17% | -$1.83M | 0.01% | 1633 |
|
|
2014
Q3 | $11.7M | Buy |
303,347
+103,557
| +52% | +$3.86M | 0.01% | 1332 |
|
|
2014
Q2 | $7.78M | Buy |
199,790
+57,187
| +40% | +$2.13M | ﹤0.01% | 1744 |
|
|
2014
Q1 | $4.88M | Sell |
142,603
-114,166
| -44% | -$3.54M | ﹤0.01% | 2037 |
|
|
2013
Q4 | $5.39M | Sell |
256,769
-427,745
| -62% | -$10.8M | ﹤0.01% | 1950 |
|
|
2013
Q3 | $16.1M | Sell |
684,514
-12,738
| -2% | -$362K | 0.01% | 1126 |
|
|
2013
Q2 | $18.7M | Buy |
+697,252
| New | +$20.2M | 0.01% | 1017 |
|
Other funds holding MYGN
O
GCM
VCM
VPM
Ameriprise's MYGN Position: Q1 2026 in Review
Ameriprise reduced its Myriad Genetics (MYGN) stake by 49% in Q1 2026, selling an estimated $1.34M and leaving 267,328 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #3211.
Ameriprise first reported a position in MYGN in Q2 2013 and has held it in 50 quarters since. The position peaked at $23.1M in Q3 2018. 202 funds tracked by Wall St. Rank hold MYGN as of Q1 2026.
- Ameriprise held 267,328 shares of Myriad Genetics worth $1.2M as of Q1 2026.
- Ameriprise sold 257,994 Myriad Genetics shares in Q1 2026, an estimated $1.34M.
- Myriad Genetics made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3211 holding.
- Ameriprise first reported a position in Myriad Genetics in Q2 2013 and has held it in 50 quarters since.
- Ameriprise's Myriad Genetics position peaked at $23.1M in Q3 2018.
- 202 funds tracked by Wall St. Rank held Myriad Genetics as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.